Carl Gordon
Chairman presso KEROS THERAPEUTICS, INC.
Patrimonio netto: 13 865 $ in data 31/03/2024
Provenienza dei contatti di primo grado di Carl Gordon
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
Massachusetts Institute of Technology
155
| College/University | Finance/Rental/Leasing | 155 |
OrbiMed Advisors Private Equity
 OrbiMed Advisors Private Equity Investment ManagersFinance OrbiMed Advisors Private Equity (OrbiMed Advisors Private Equity) is a private equity and venture capital subsidiary of Orbimed Advisors LLC founded in 1993 by Samuel D. Isaly. The firm is headquartered in New York and it has additional offices in San Francisco, Mumbai, Shanghai, Herzliya, Hong Kong and London.
74
| Subsidiary | Investment Managers | 74 |
OrbiMed Advisors LLC
 OrbiMed Advisors LLC Investment ManagersFinance OrbiMed Advisors LLC is an independent, SEC-registered investment advisor and hedge fund manager headquartered in New York City. It was founded by Sven Borho and Carl Gordon in 1989. The firm provides discretionary investment management services to US and non-US public and private funds.
50
| Private Company | Investment Managers | 50 |
29
| Subsidiary | Pharmaceuticals: Major | 29 |
Singulex, Inc.
 Singulex, Inc. Miscellaneous Commercial ServicesCommercial Services Singulex, Inc. provides biotechnological research and development services. It also provides instrumentation and immunoassays with the requisite sensitivity and specificity to enable biomarker discovery and validation for drug safety and efficacy. The company was founded by Robert S. Puskas in November 1997 and is headquartered in Alameda, CA.
28
| Private Company | Miscellaneous Commercial Services | 28 |
27
| Extinct | Biotechnology | 27 |
| Subsidiary | Pharmaceuticals: Major | 22 | |
| Public Company | Pharmaceuticals: Major | 21 | |
| Public Company | Pharmaceuticals: Major | 20 | |
| Public Company | Biotechnology | 19 | |
| Public Company | Biotechnology | 18 | |
Arsanis, Inc.
 Arsanis, Inc. BiotechnologyHealth Technology Arsanis, Inc. operates as a clinical-stage biotechnology company, which engages in provision of monoclonal antibody immunotherapies to address serious infectious diseases. The company was founded by Eszter Nagy, Tillman U. Gerngross, and Errik B. Anderson on August 2, 2010 and is headquartered in Waltham, MA.
17
| Extinct | Biotechnology | 17 |
| Subsidiary | Biotechnology | 16 | |
| Public Company | Pharmaceuticals: Major | 14 | |
| Subsidiary | Pharmaceuticals: Major | 14 | |
| Public Company | Pharmaceuticals: Major | 13 | |
| Public Company | Biotechnology | 13 | |
| Extinct | Biotechnology | 12 | |
| Subsidiary | Biotechnology | 11 | |
Arius Research, Inc.
 Arius Research, Inc. BiotechnologyHealth Technology Arius Research, Inc. develops anti-cancer antibodies. The company is headquartered in Toronto, Canada.
11
| Extinct | Biotechnology | 11 |
| Subsidiary | Biotechnology | 11 | |
| Public Company | Biotechnology | 9 | |
| Public Company | Pharmaceuticals: Major | 9 | |
Garuda Therapeutics, Inc.
 Garuda Therapeutics, Inc. BiotechnologyHealth Technology Garuda Therapeutics, Inc. aims to eliminate the need for donor or patient cells for blood stem cell transplants. The company is based in Natick, MA. The company's platform technology generates off-the-shelf, self-renewing blood stem cells that are HLA-compatible and transgene-free. This technology could potentially provide curative therapies for over 120 diseases. Garuda Therapeutics was founded by Dhvanit Shah, Sean Morrison, and David T. Scadden, with Dhvanit Shah serving as CEO since incorporation.
8
| Holding Company | Biotechnology | 8 |
Odyssey Therapeutics, Inc.
 Odyssey Therapeutics, Inc. Packaged SoftwareTechnology Services Odyssey Therapeutics, Inc. is a biotechnology company that specializes in discovering, developing, and commercializing immunomodulators and oncology medicines. The company is based in Medfield, MA and has subsidiaries in the United Kingdom. The company is composed of a team of drug hunters, scientists, and industry leaders in foundational biology, chemistry, and data sciences. Odyssey Therapeutics aims to transform drug discovery to accelerate and drive the creation and efficient delivery of life-enhancing precision medicines to patients. Odyssey Therapeutics was founded by David L. Pompliano, Gary D. Glick, and Melissa Merrick, with Gary D. Glick serving as the CEO since incorporation.
7
| Holding Company | Packaged Software | 7 |
Gemini Therapeutics Sub, Inc.
 Gemini Therapeutics Sub, Inc. BiotechnologyHealth Technology Gemini Therapeutics Sub, Inc. engages in the development of treatments for age-related macular degeneration (AMD) and linked ocular disorders. Its multimodal pipeline includes monoclonal antibodies, recombinant proteins and gene therapies. The company was founded by James McLaughlin, Johanna Seddon, Paul Barlow and Andrew Herbert in 2015 and is headquartered in Cambridge, MA.
7
| Subsidiary | Biotechnology | 7 |
| Public Company | Pharmaceuticals: Major | 7 | |
Kumquat Biosciences, Inc.
 Kumquat Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Kumquat Biosciences, Inc. provides biotechnology services. The company was founded by Yi Liu and Pingda Ren and is headquartered in San Diego, CA.
5
| Private Company | Miscellaneous Commercial Services | 5 |
Xinthera, Inc.
 Xinthera, Inc. Pharmaceuticals: MajorHealth Technology Part of Gilead Sciences, Inc., XinThera, Inc. is a drug discovery company focused on building a small molecule oncology and immunology pipeline. The private company is based in San Diego, CA. XinThera is backed by a group of international investors including Foresite Capital, OrbiMed Advisors, LLC, and TTM Capital. XinThera's lead programs focus on well-validated targets with a mission to rapidly create and advance fast-follower programs with potential in areas of high-unmet need. XinThera was founded by Qing Dong, Stephen W. Kaldor, and Gene Hung. The CEO is Christopher C. LeMasters.
5
| Subsidiary | Pharmaceuticals: Major | 5 |
| Public Company | Biotechnology | 5 | |
MBX Biosciences, Inc.
 MBX Biosciences, Inc. Electronic Equipment/InstrumentsElectronic Technology MBX Biosciences, Inc. operates as a preclinical-stage biotech company. It creates therapies to treat rare endocrine diseases. The company was founded by Peter Kent Hawryluk and Timothy Knickerbocker and is headquartered in Carmel, IN.
5
| Holding Company | Electronic Equipment/Instruments | 5 |
| Public Company | Pharmaceuticals: Major | 5 | |
Sapphire Therapeutics, Inc.
 Sapphire Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Sapphire Therapeutics, Inc. develops biopharmaceutical products. It develops compounds for the treatment of oncologic and metabolic diseases. The firm products include anamorelin for the treatment of anorexia and cachexia. The company was founded in 2000 and is headquartered in Bridgewater, NJ.
5
| Subsidiary | Pharmaceuticals: Major | 5 |
Emendo Biotherapeutics, Inc.
 Emendo Biotherapeutics, Inc. BiotechnologyHealth Technology Emendo Biotherapeutics, Inc. engages in the development of genome editing technology. It specializes in protein engineering, molecular biology, and gene editing systems. The company was founded by David Baram, Lior Izhar, and Rachel Diamant in 2015 and is headquartered in New York, NY.
4
| Subsidiary | Biotechnology | 4 |
Electra Therapeutics, Inc.
 Electra Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Electra Therapeutics, Inc. is a clinical stage biotechnology company that develops therapies for the treatment of immunological diseases and cancer. The company is based in San Francisco, CA. The company's lead product candidate, ela026, is a monoclonal antibody that targets sirp on the cell surface of and t cells, and precisely depletes pathological immune cells. Electra currently has one program in clinical development and additional preclinical programs. The company was founded by Adam Rosenthal, who has been the CEO since incorporation.
4
| Holding Company | Pharmaceuticals: Major | 4 |
Blossomhill Therapeutics, Inc.
 Blossomhill Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Blossomhill Therapeutics, Inc. is a small molecule drug discovery and development company that focuses on unmet medical needs in oncology and autoimmune disorders. The company is based in San Diego, CA. Dr. Cui is the lead inventor of multiple oncology medicines and clinical compounds, including crizotinib, lorlatinib, repotrectinib (TPX-0005), TPX-0022, TPX-0046, and TPX-0131. The company was founded by J. Jean Cui, Ph.D., a renowned drug design and development scientist, and Y. Peter Li, Ph.D., M.B.A., a biotech veteran. Jing Rong Cui has been the CEO since incorporation.
4
| Holding Company | Pharmaceuticals: Major | 4 |
Amnis Corp.
 Amnis Corp. BiotechnologyHealth Technology Amnis Corp. provides cell imaging and instrument development, manufacturing and marketing services. The Company's ImageStreamX and FlowSight imaging flow cytometers combine the speed and sensitivity of flow cytometry with the power of digital microscopy serving a broad spectrum of Life Sciences research market needs. The company was founded by David A. Basiji, William E. Ortyn and Harold H. Kawaguchi in 1999 and is headquartered in Seattle, WA.
3
| Subsidiary | Biotechnology | 3 |
Agensys, Inc.
 Agensys, Inc. Miscellaneous Commercial ServicesCommercial Services Agensys, Inc. develops a pipeline of therapeutic fully human monoclonal atibodies (mAbs) to treat cancer. It develops a pipeline of naked and antibody-drug conjugated (ADC) therapeutic antibodies to treat cancer indications, including prostate, kidney, pancreas, ovary, bladder, lung, colon, breast, and skin. The company was founded in 1997 and is headquartered in Santa Monica, CA.
3
| Subsidiary | Miscellaneous Commercial Services | 3 |
Star Therapeutics, Inc.
 Star Therapeutics, Inc. BiotechnologyHealth Technology Star Therapeutics, Inc. is an American company that aims to develop life-changing therapies for rare diseases. The company's mission is to help millions of patients in urgent need. The company was founded by Adam Rosenthal, who has been the CEO since incorporation.
2
| Holding Company | Biotechnology | 2 |
Balance Therapeutics, Inc.
 Balance Therapeutics, Inc. BiotechnologyHealth Technology Balance Therapeutics, Inc. develops therapeutics to address conditions of intellectual disability. Its pharmacological approach, based on technology licensed from Stanford University, hypothesizes that restoring the proper balance between inhibition and excitation at the neuronal synapse by antagonizing excessive inhibitory circuits could result in the appropriate plasticity for memory and learning to occur in many conditions of intellectual disability. The company was founded by Lyndon Lien, Craig Garner and Daniel Wetmore in 2009 and is headquartered in San Bruno, CA.
1
| Holding Company | Biotechnology | 1 |
Frontera Therapeutics (HK) Ltd.
 Frontera Therapeutics (HK) Ltd. Pharmaceuticals: MajorHealth Technology Part of Frontera Therapeutics, Inc., Frontera Therapeutics (HK) Ltd. is a Chinese pharmaceutical company that manufactures pharmaceutical products. The private company was founded by Yong Dai and Yong Dai has been the CEO since incorporation.
1
| Subsidiary | Pharmaceuticals: Major | 1 |
Gwynant Therapeutics
 Gwynant Therapeutics Pharmaceuticals: MajorHealth Technology Gwynant Therapeutics develops new small molecules for oncology targets.
1
| Holding Company | Pharmaceuticals: Major | 1 |
X4 Pharmaceuticals (Austria) GmbH
1
| Subsidiary | 1 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Carl Gordon tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Director of Finance/CFO Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Investor Relations Contact | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Sales & Marketing Sales & Marketing Corporate Officer/Principal Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Executive Officer Corporate Officer/Principal | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Sales & Marketing General Counsel Chief Tech/Sci/R&D Officer | |
| BIOGEN INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer General Counsel Corporate Officer/Principal Corporate Officer/Principal | |
| ALEXION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | General Counsel Founder Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| INTERMUNE INC | Biotechnology | Director/Board Member Director/Board Member Corporate Officer/Principal | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| AMBIT BIOSCIENCES CORP | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member Chief Tech/Sci/R&D Officer | |
| INTERCEPT PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Investor Relations Contact General Counsel | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member Chairman Director/Board Member | |
| GELESIS INC | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
| CENTREXION THERAPEUTICS CORPORATION | Pharmaceuticals: Major | Founder Director/Board Member Director of Finance/CFO | |
Compass Therapeutics LLC
 Compass Therapeutics LLC BiotechnologyHealth Technology Compass Therapeutics LLC operates as a healthcare industry focusing on biotechnology. It offers drug discovery, development, biologics, oncology and immuno-oncology. The company was founded by Errik B. Anderson and Thomas J. Schuetz in 2014 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member Director/Board Member Corporate Officer/Principal | |
| The Trustees of Columbia University in The City of New York | College/University | Doctorate Degree Graduate Degree Doctorate Degree Undergraduate Degree Doctorate Degree | |
| Dartmouth College | College/University | Undergraduate Degree Undergraduate Degree Corporate Officer/Principal Undergraduate Degree | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree Undergraduate Degree Doctorate Degree Doctorate Degree Doctorate Degree Graduate Degree | |
| Stanford University | College/University | Masters Business Admin Corporate Officer/Principal Graduate Degree Undergraduate Degree Undergraduate Degree Graduate Degree | |
The Boston Consulting Group, Inc.
 The Boston Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services The Boston Consulting Group, Inc. engages in the provision of management consulting services. It specializes in automotive and mobility; biopharmaceuticals; consumer products; education; oil and gas; power and utilities; engineered products and infrastructure; financial institutions; and health care payers, providers, and services. It offers big data and advanced analytics; change management; client learning and enablement; and corporate development and financial services. The company was founded by Bruce Doolin Henderson in 1963 and is headquartered in Boston, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Consultant / Advisor | |
The American Institute of Certified Public Accountants
 The American Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services The American Institute of Certified Public Accountants provides vocational education in accounting. The company provides services to the accounting community, regulatory bodies, and other organizations. It also operates in Jersey City, Washington, and Lewisville. It was founded in 1887 and is headquartered in New York City, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| University of California, Los Angeles | College/University | Doctorate Degree Undergraduate Degree Undergraduate Degree | |
| Yale University | College/University | Corporate Officer/Principal Doctorate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree Doctorate Degree | |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Director/Board Member Graduate Degree Doctorate Degree | |
| Tufts University | College/University | Director/Board Member Corporate Officer/Principal Undergraduate Degree | |
The Ohio State University
 The Ohio State University Other Consumer ServicesConsumer Services Global Factory, Inc. provides collaborative manufacturing execution systems. The firm's software gather, organize & analyze demand, production & quality data from various sources and monitor key indicators & execute business processes to control, manage & optimize distributed manufacturing operations. The company was founded in 1999 and is headquartered in Santa Clara, CA. | College/University | Doctorate Degree Doctorate Degree Undergraduate Degree | |
| INSEAD | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
| University of California, Berkeley | College/University | Undergraduate Degree Masters Business Admin Undergraduate Degree | |
| AMBRX INC | Pharmaceuticals: Major | Founder Chief Executive Officer Director/Board Member Director/Board Member | |
| University of Science & Technology of China | College/University | Undergraduate Degree Graduate Degree Undergraduate Degree | |
| Harvard Medical School | College/University | Doctorate Degree Director/Board Member Corporate Officer/Principal Doctorate Degree Doctorate Degree | |
Avitide, Inc.
 Avitide, Inc. BiotechnologyHealth Technology Avitide, Inc. develops affinity purification solutions. Its technology enables development of chromatography resins via chemical synthesis which are not based on costly recombinant proteins. The company was founded by Errik B. Anderson, Warren Kett, Tillman U. Gerngross, Kevin Isett and Jonathan Sheller in 2012 and is headquartered in Lebanon, NH. | Biotechnology | Director/Board Member Director/Board Member Founder | |
| LOXO ONCOLOGY INC | Pharmaceuticals: Major | Director/Board Member Director/Board Member President Chief Tech/Sci/R&D Officer | |
| AUDENTES THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director/Board Member General Counsel | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin Undergraduate Degree Masters Business Admin | |
| Harvard College | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
NightstaRx Ltd.
 NightstaRx Ltd. Medical/Nursing ServicesHealth Services NightstaRx Ltd. develops and commercializes therapies for retinal dystrophies. It offers retinal gene therapy that provides one-time cure for choroideremia (a rare inherited cause of blindness) and other retinal dystrophies. The company was founded by Robert MacLaren, Miguel Seabra, and Matthew During in January 2014 and is headquartered in London, the United Kingdom. | Medical/Nursing Services | Director/Board Member Director/Board Member Director/Board Member | |
| PASSAGE BIO, INC. | Biotechnology | Chief Executive Officer Director/Board Member Director/Board Member Director/Board Member Chief Operating Officer | |
SpringWorks Therapeutics LLC
 SpringWorks Therapeutics LLC BiotechnologyHealth Technology SpringWorks Therapeutics, Inc. engages in the development of biopharmaceutical products for patients with severe rare diseases and cancer. It focuses in advancing the pipeline of standalone and combination therapies with an initial focus on rare diseases and oncology. The company was founded by Lara S. Sullivan in 2017 and is headquartered in Stamford, CT. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member Chief Executive Officer | |
California Life Sciences Association
 California Life Sciences Association Miscellaneous Commercial ServicesCommercial Services California Life Sciences Association (CLSA) is the largest and most influential life sciences advocacy and business leadership organization in California. The non-profit company is based in South San Francisco, CA, and has offices in other locations as well. The company works closely with industry, government, academia, and others to shape public policy, improve access to innovative technologies, and grow California's life sciences economy. CLSA serves biotechnology, pharmaceutical, medical device, and diagnostics companies, research universities and institutes, investors, and service providers throughout the state. Mike Guerra has been the CEO of the company since 2019. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member | |
| NIGHTSTAR THERAPEUTICS PLC | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member General Counsel | |
| ENLIVEN THERAPEUTICS, INC. | Biotechnology | Director of Finance/CFO Director/Board Member Director/Board Member | |
| X4 PHARMACEUTICALS, INC. | Biotechnology | Chief Executive Officer Founder Chief Executive Officer |
Statistiche
Distribuzione geografica
| Stati Uniti | 46 |
| Regno Unito | 4 |
| Francia | 2 |
| Cina | 2 |
Settori
| Health Technology | 29 |
| Consumer Services | 16 |
| Commercial Services | 5 |
| Finance | 3 |
| Health Services | 2 |
Posizioni
| Director/Board Member | 708 |
| Corporate Officer/Principal | 272 |
| Independent Dir/Board Member | 229 |
| Chief Executive Officer | 122 |
| Chairman | 120 |
Contatti più connessi
| Insiders | |
|---|---|
| James Tananbaum | 60 |
| James Healy | 50 |
| Jeffrey Kindler | 47 |
| Stephen P. Squinto | 40 |
| Georges Gemayel | 33 |
| Louis Lavigne | 32 |
| Iain Dukes | 30 |
| Joseph Zakrzewski | 30 |
| Rishi Gupta | 29 |
| Freda Lewis-Hall | 29 |
| Hong Bo Lu | 28 |
| David Bonita | 27 |
| Richard Scheller | 27 |
| Lori Kunkel | 27 |
| Mary Gray | 27 |
- Borsa valori
- Insiders
- Carl Gordon
- Connessioni Società
